These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27740636)

  • 21. [The Relationship between Occurrence of aGVHD in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation and Immune Cell Components in Graft].
    Liu S; Zhou Z; Zhai WJ; Song XN; Li Q; Jiang EL; Feng SZ; Sun JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):539-545. PubMed ID: 37096531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation].
    Niu YY; Ma LM; Zhou Y; Ren RR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):735-9. PubMed ID: 20561440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD27 on peripheral CD4+ T-lymphocytes correlates with the development of severe acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Yoshida H; Maeda T; Ishikawa J; Inoue S; Matsunaga H; Kosugi S; Shiraga M; Oritani K; Kanakura Y; Tomiyama Y
    Int J Hematol; 2006 Nov; 84(4):367-76. PubMed ID: 17118766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of pre-transplant circulating CD3
    Kim TW; Lee SE; Lim JY; Ryu DB; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27910184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease].
    Wang ZD; Feng SZ; Zhou SY; Wang M; Zhou Z; Zhai WJ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1215-20. PubMed ID: 17204197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD161(+) T cells as predictive markers for acute graft-versus-host disease.
    Lee SE; Lim JY; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):421-8. PubMed ID: 25543092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
    Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractions.
    Tsuchiyama J; Yoshino T; Saito T; Furukawa T; Ito K; Fuse I; Aizawa Y
    Bone Marrow Transplant; 2009 Jun; 43(11):863-73. PubMed ID: 19043457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation.
    Cho BS; Min CK; Kim HJ; Lee S; Kim YJ; Lim JY; Jeong DC; Cho B; Kim HK; Eom KS; Cho SG; Kim DW; Lee JW; Min WS; Kim CC; Chung NG
    Biol Blood Marrow Transplant; 2010 May; 16(5):629-38. PubMed ID: 19963070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of invariant NKT cells in allogeneic hematopoietic stem cell transplantation.
    Karadimitris A; Chaidos A
    Crit Rev Immunol; 2012; 32(2):157-71. PubMed ID: 23216613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
    Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.
    Zhao XY; Chang YJ; Xu LP; Liu DH; Liu KY; Huang XJ
    Bone Marrow Transplant; 2009 Dec; 44(11):721-8. PubMed ID: 19377516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.